Provided by Tiger Fintech (Singapore) Pte. Ltd.

Adial Pharmaceuticals

0.3351
-0.1347-28.67%
Post-market: 0.3100-0.0251-7.49%19:59 EDT
Volume:15.28M
Turnover:5.49M
Market Cap:5.29M
PE:-0.22
High:0.4050
Open:0.3700
Low:0.3110
Close:0.4698
Loading ...

Adial Pharmaceuticals (ADIL) Receives a Buy from Brookline Capital Markets

TIPRANKS
·
28 Jun

BRIEF-Adial Pharmaceuticals Secures Agreements With Cambrex And Thermo Fisher Scientific

Reuters
·
25 Jun

Adial Pharmaceuticals secures U.S.-based manufacturing through agreements

TIPRANKS
·
25 Jun

Adial Pharmaceuticals Secures U.S.-Based Manufacturing Through Agreements With Cambrex and Thermo Fisher Scientific for Drug Substance and Drug Product Supply

THOMSON REUTERS
·
25 Jun

Adial Pharmaceuticals Inc - Executes Agreements for Ad04 Production

THOMSON REUTERS
·
25 Jun

Adial Pharmaceuticals Completes $3.6M Public Offering

TIPRANKS
·
19 Jun

Adial Pharmaceuticals prices 11.1M shares at 32.51c in public offering

TIPRANKS
·
17 Jun

Adial Pharmaceuticals Announces Pricing of $3.6 Million Public Offering

THOMSON REUTERS
·
17 Jun

Adial Pharmaceuticals Reschedules 2025 Annual Meeting Date

TIPRANKS
·
17 Jun

Adial Pharmaceuticals Inc - FDA Reschedules End of Phase 2 Meeting to July 29

THOMSON REUTERS
·
16 Jun

Adial Pharmaceuticals Submits Briefing Package to Guide Upcoming FDA Meeting

THOMSON REUTERS
·
16 Jun

Adial Pharmaceuticals Advances Toward Phase 3 Development for Ad04

THOMSON REUTERS
·
11 Jun

Adial Pharmaceuticals files to sell 7.59M shares of common stock, warrants

TIPRANKS
·
06 Jun

Adial Pharmaceuticals files to sell 6.73M shares of common stock for holders

TIPRANKS
·
31 May

Adial Pharmaceuticals Inc. Faces Nasdaq Delisting Risk Due to Noncompliance with Listing Rule

Reuters
·
31 May

Adial Pharmaceuticals Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
17 May

Adial Pharmaceuticals Q1 EPS $(0.34) Beats $(0.50) Estimate

Benzinga
·
15 May

Adial Pharmaceuticals Reports Q1 2025 Results: Net Loss Narrows to $2.2M, Driven by Reduced Inducement Expense

Reuters
·
15 May

Adial Pharmaceuticals Reports First Quarter 2025 Financial Results and Provides Business Update

THOMSON REUTERS
·
15 May

Adial Pharmaceuticals Q1 Net Income USD -2.2 Million

THOMSON REUTERS
·
15 May